Abstract
The prevalence of abdominal aortic aneurysm (AAA) in general population is 4-9% with a high mortality rate when ruptured. Therefore, screening programs were developed in many countries to detect small and large AAA in selected patients. Indeed, prevalence of AAA increases in patients over 65 years old with cigarette smoking history. This paper reviews recent literature related to AAA screening focusing on epidemiology, screening tests and evidence based medicine to highlight not only advantages but also disadvantages of screening programs among population.
Keywords: Abdominal aortic aneurysm, screening, risk factors, ultrasonography.
Current Pharmaceutical Design
Title:Abdominal Aortic Aneurysm: What About Screening?
Volume: 21 Issue: 28
Author(s): Francois Saucy, Sebastien Déglise, Thomas Holzer, Lukas Briner, Marie Benezit, Charline Delay, Caroline Kazandjian and Jean-Marc Corpataux
Affiliation:
Keywords: Abdominal aortic aneurysm, screening, risk factors, ultrasonography.
Abstract: The prevalence of abdominal aortic aneurysm (AAA) in general population is 4-9% with a high mortality rate when ruptured. Therefore, screening programs were developed in many countries to detect small and large AAA in selected patients. Indeed, prevalence of AAA increases in patients over 65 years old with cigarette smoking history. This paper reviews recent literature related to AAA screening focusing on epidemiology, screening tests and evidence based medicine to highlight not only advantages but also disadvantages of screening programs among population.
Export Options
About this article
Cite this article as:
Saucy Francois, Déglise Sebastien, Holzer Thomas, Briner Lukas, Benezit Marie, Delay Charline, Kazandjian Caroline and Corpataux Jean-Marc, Abdominal Aortic Aneurysm: What About Screening?, Current Pharmaceutical Design 2015; 21 (28) . https://dx.doi.org/10.2174/1381612821666150826095148
DOI https://dx.doi.org/10.2174/1381612821666150826095148 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modern drug delivery systems for targeting the posterior segment of the eye
Current Pharmaceutical Design Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Recent Patents Relating to Diagnostic Advances in Age Related Macular Degeneration (AMD)
Recent Patents on DNA & Gene Sequences Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
Current Medicinal Chemistry Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Microbleeds after Stent-assisted Coil Embolization of Unruptured Intracranial Aneurysms: Incidence, Risk Factors and the Role of Thromboelastography
Current Neurovascular Research Diagnosis and Management of Chronic Coronary Artery Disease
Current Cardiology Reviews Matrix Metalloproteinases as Drug Targets in Preeclampsia
Current Drug Targets Three-dimensional Printing-Driving Liver Therapies
Current Medicinal Chemistry Delayed Multiple Non-ischemic Cerebral Enhanced Lesions After Endovascular Therapy For Left Internal Carotid Aneurysm: A Case Report
Current Medical Imaging Statins Exert Multiple Beneficial Effects on Patients Undergoing Percutaneous Revascularization Procedures
Current Drug Targets Efficacy, Duration and Timing of Withdrawal of Prophylactic Treatment with Antiepileptic Drugs in Neurosurgical Conditions
Current Pharmaceutical Design Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives
Current Pharmaceutical Design Contribution of Platelet-Derived CD40 Ligand to Inflammation, Thrombosis and Neoangiogenesis
Current Medicinal Chemistry Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
Current Pharmaceutical Design Pathophysiology of Coronary Thrombus Formation and Adverse Consequences of Thrombus During PCI
Current Cardiology Reviews Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Automated Computerized Method for the Detection of Unruptured Cerebral Aneurysms in DSA Images
Current Medical Imaging The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis